Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1664735

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Transgender People: Young People
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that young people considering gender transition have adequate access to information about long-term health effects of gender reassignment surgery and drugs.
tabling member printed	Baroness Deech
uin	HL10514
answer	answer is ministerial correction date of answer 26/10/2023 answer text <p>It has not proved possible to respond to this question in the time available before Prorogation. Ministers will correspond directly with the Member.</p> answering member printed Lord Markham question first answered 26/10/2023 10:56:00 answering member 4948 label Biography information for Lord Markham
tabling member	3756 label Biography information for Baroness Deech

1664736

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children and Young People
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, following the Children's Society's The Good Childhood Report 2023, published on 20 September, what steps the Department of Health and Social Care's Major Conditions Strategy will take to prevent poor mental health and promote wellbeing in children and young people.
tabling member printed	The Lord Bishop of Derby
uin	HL10519
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>As part of the development of the Major Conditions Strategy, we are considering the most effective ways to prevent and treat poor mental health and promote wellbeing for people of all ages. We will continue to work closely with stakeholders, the public and the National Health Service to identify actions that will have the most impact.</p> answering member printed Lord Markham question first answered 24/10/2023 12:17:56 answering member 4948 label Biography information for Lord Markham
tabling member	4714 label Biography information for The Lord Bishop of Derby

1664741

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Children: Health
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the Children's Society's The Good Childhood Report 2023, published on 20 September, and what plans they have to implement its recommendations to promote the wellbeing of children.
tabling member printed	The Lord Bishop of Durham
uin	HL10524
answer	answer is ministerial correction date of answer 25/10/2023 answer text <p>The Government is grateful for the Good Childhood Report and has noted its findings. The Children’s Commissioner’s Family Review covers similar issues and the Government’s response to this will be published imminently.</p><p>The recommendation to create a cabinet level minister for children was addressed in the Government’s response to the final report of the Independent Inquiry into Child Sexual Abuse. We accept the importance of placing the best interests of the child front and centre in policy and decision making at the highest level of government. This role is already fulfilled through the work of the Secretary of State for Education.</p><p>We are implementing the proposals of the Government’s Transforming children and young people’s mental health Green Paper which includes establishing mental health support teams in schools and providing training to Senior Mental Health leads in schools.</p><p>The Department for Education publishes an annual State of the Nation report into Children’s wellbeing. The report brings together a range of published information from government, academic, voluntary, and private sector organisations to provide a clear narrative for all those interested in the wellbeing of children and young people in England. It provides a shared evidence base for everyone – in government, services, schools and colleges, parents and families, communities, and employers – to reflect upon and deliver better wellbeing outcomes for all children and young people.</p> answering member printed Lord Markham question first answered 25/10/2023 11:24:04 answering member 4948 label Biography information for Lord Markham
tabling member	4312 label Biography information for The Lord Bishop of Durham

1664750

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the report by the All-Party Parliamentary Group on Brain Tumours, Pathway to a Cure – breaking down the barriers, published on 28 February 2023, what is the expected timescale to develop a strategy for adequately resourcing discovery, translational and clinical research into brain tumours as recommended by the report; and whether they will commit to ring fencing the recommended £110 million for this resourcing.
tabling member printed	Baroness Hayter of Kentish Town
uin	HL10540
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>The Department of Health and Social Care welcomes the All-Party Parliamentary Group report, recommendations of which continue to be worked through with the Department for Science, Innovation and Technology, UK Research and Innovation and the Medical Research Council (MRC), and with the National Institute for Health and Care Research (NIHR).</p><p>The report recommended action by the research funding agencies on coordinating activities and making funding available. We are taking steps to ensure that funders work closely together to coordinate work along the translational pathway, from the discovery and early translational science typically supported by the MRC, feeding through to the applied health and care research funded by the NIHR.</p><p>It is not usual practice to ring-fence funds for particular topics or conditions. As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. The level of research spend in a particular area is driven by factors including scientific potential and the number and scale of successful funding applications.</p> answering member printed Lord Markham question first answered 24/10/2023 12:16:58 answering member 4948 label Biography information for Lord Markham
tabling member	4159 label Biography information for Baroness Hayter of Kentish Town

1664761

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the proposed update to the 2023 Statutory Scheme to control the cost of branded health services medicines, what policy options were included in the Department of Health and Social Care's long list as alternatives to the options that were included in the final consultation.
tabling member printed	Lord Warner
uin	HL10591
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>The statutory scheme consultation sets out the options under consideration. We are in the process of analysing the responses provided, including consideration of any alternative options proposed, and will update on our preferred policy approach later this year. A copy of the impact assessment is attached.</p> answering member printed Lord Markham question first answered 24/10/2023 12:17:36 answering member 4948 label Biography information for Lord Markham attachment 1 file name Statutory Scheme Impact Assessment.pdf title Statutory Scheme Impact Assessment
tabling member	1732 label Biography information for Lord Warner

1664762

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what is the evidence that the Department of Health and Social Care used to support the statement in the consultation on the Statutory Scheme to control the cost of branded health services medicines that investment in research and development in the UK was not a "net benefit".
tabling member printed	Lord Warner
uin	HL10592
answer	answer is ministerial correction date of answer 23/10/2023 answer text <p>The approach to assessing the potential impacts on investment within the statutory scheme’s impact assessment followed well-established precedent and is in line with the Green Book paragraphs 6.5 and 6.6. As such, the impact assessment considers spillover benefits of investment, with a literature review suggesting an estimated mean benefit of 34% of the overall investment, but does not account for these within the net present value calculation due to investment being one of several possible company responses to change in profitability.</p> answering member printed Lord Markham question first answered 23/10/2023 09:57:20 answering member 4948 label Biography information for Lord Markham
tabling member	1732 label Biography information for Lord Warner

1664763

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the proposed update to the 2023 Statutory Scheme to control the cost of branded health services medicines, what analysis and evidence the Department of Health and Social Care considered when it proposed to keep growth in the cost of branded medicines in real-terms decline, at 2 per cent a year.
tabling member printed	Lord Warner
uin	HL10593
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>2% allowed growth per annum represents an 80% rise in allowed growth compared to the 1.1% per annum which applied in the statutory scheme from 2019 to 2023. The proposal is consistent with the approach that underpinned the current statutory scheme’s 1.1% allowed growth, i.e., it equals the average allowed growth of the preceding voluntary scheme.</p><p>The proposed allowed growth rate considered multiple factors including the overall fiscal path. Furthermore, consideration of the pipeline of upcoming new treatments featured within our forecast growth in spend on new treatments and, ultimately, continued growth forecast in medicine sales.</p><p>Controlling growth at this level is considered to allow for a viable overall envelope for the statutory scheme more favourable for industry compared to the existing statutory scheme arrangements, whilst continuing to ensure that spend on branded medicines is affordable to the National Health Service.</p> answering member printed Lord Markham grouped question UIN HL10594 question first answered 24/10/2023 11:37:30 answering member 4948 label Biography information for Lord Markham
tabling member	1732 label Biography information for Lord Warner

1664764

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Proposed update to the 2023 Statutory Scheme to control the cost of branded medicines, whether the 2 per cent cap in growth in the cost of branded medicines was assessed against (1) inflation expectations, and (2) demographic pressures.
tabling member printed	Lord Warner
uin	HL10594
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>2% allowed growth per annum represents an 80% rise in allowed growth compared to the 1.1% per annum which applied in the statutory scheme from 2019 to 2023. The proposal is consistent with the approach that underpinned the current statutory scheme’s 1.1% allowed growth, i.e., it equals the average allowed growth of the preceding voluntary scheme.</p><p>The proposed allowed growth rate considered multiple factors including the overall fiscal path. Furthermore, consideration of the pipeline of upcoming new treatments featured within our forecast growth in spend on new treatments and, ultimately, continued growth forecast in medicine sales.</p><p>Controlling growth at this level is considered to allow for a viable overall envelope for the statutory scheme more favourable for industry compared to the existing statutory scheme arrangements, whilst continuing to ensure that spend on branded medicines is affordable to the National Health Service.</p> answering member printed Lord Markham grouped question UIN HL10593 question first answered 24/10/2023 11:37:30 answering member 4948 label Biography information for Lord Markham
tabling member	1732 label Biography information for Lord Warner

1664765

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to refer the Impact Assessment for the 2023 Statutory Scheme to control the cost of branded health services medicines to the Regulatory Policy Committee.
tabling member printed	Lord Warner
uin	HL10595
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>There are no plans to refer the statutory scheme Impact Assessment to the Regulatory Policy Committee. The proposals only impact companies which choose to sell to the National Health Service and are therefore considered to be in connection with procurement. Given this, the statutory exclusion from the Better Regulation Framework “Procurement 22(4)(b)” applies as confirmed previously by the Economic and Domestic Affairs Secretariat at the Cabinet Office.</p> answering member printed Lord Markham question first answered 24/10/2023 12:18:19 answering member 4948 label Biography information for Lord Markham
tabling member	1732 label Biography information for Lord Warner

1664766

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to introduce an end of scheme reconciliation exercise for the Statutory Scheme to control the cost of branded health services medicines.
tabling member printed	Lord Warner
uin	HL10596
answer	answer is ministerial correction date of answer 24/10/2023 answer text <p>No end of scheme reconciliation exercise was proposed in the recent consultation on updating the statutory scheme. We are in the process of considering consultation responses.</p> answering member printed Lord Markham question first answered 24/10/2023 11:37:59 answering member 4948 label Biography information for Lord Markham
tabling member	1732 label Biography information for Lord Warner